Latest Ibritumomab tiuxetan Stories

2008-10-07 09:00:55

Genentech and Biogen Idec have announced that a global Phase III study of Rituxan in combination with fludarabine and cyclophosphamide chemotherapy met its primary endpoint of improving progression-free survival, as assessed by investigators, in patients with previously treated CD20-positive chronic lymphocytic leukemia compared to chemotherapy alone.

2008-10-03 09:00:07

Cell Therapeutics, a biopharmaceutical company, has submitted a supplemental biologics license application to the FDA for use of Zevalin as consolidation therapy after remission induction in previously untreated patients with follicular non-Hodgkin's lymphoma.

2008-10-02 03:00:18

SEATTLE, Oct. 2 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it has submitted a supplemental Biologics License Application (sBLA) with the U.S.

2008-09-24 03:00:09

By DeNardo, Gerald Advances in imaging technology have made it possible to view molecular pathways within living individuals as never before.

2008-09-22 12:00:38

Cell Therapeutics has announced that following a meeting with the FDA data from the first-line indolent trial would be sufficient to support a submission for a supplemental biologics license application.

2008-09-22 03:00:12

SEATTLE, Sept. 22 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) announced today that following a meeting with the U.S.

2008-09-17 12:00:35

InNexus Biotechnology, a drug development company, has announced the results of an extensive mouse tumor study demonstrating superiority of the company's DXL625 compared to Rituxan in the xenograft model.

2008-09-02 09:00:43

SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the appointment of Patrick O'Connor, PhD, Vice President, Research, Michael J.

2008-08-21 09:01:14

SOUTH SAN FRANCISCO, Calif., Aug. 21 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. announced today that Christine A. White, M.D. has been appointed to the company's board of directors.

2008-08-05 03:00:11

SEATTLE, Aug. 5 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company") (Nasdaq: CTIC; MTA) t announced that Craig W. Philips has assumed his role as CTI's new President, and will concentrate on managing the company's drug development and commercial operations.

Word of the Day
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.